In December 2018, the Italian research company, Corvelva, released an explosive research paper. Vaxxter reported on their findings, exposing the ingredients in the vaccine Infanrix Hexa, the combination vaccine given to infants across Europe. Of course, the pro-vaccine machine immediately went into high gear, attacking and discrediting Corvelva’s testing methodologies. In response, Corvelva issued a technical report documenting their methods, declaring:
Protein detection is carried out using a standard approach using trypsin enzyme, a technique that has been internationally recognized for over 10 years. The peptides are then separated using chromatography and analyzed by mass spectrometry.
With this technology, there should be little doubt about the accuracy of their findings which concluded that Infanrix Hexa:
- Has a molecular profile that is generally complex and largely unknown.
- Contains protein contaminations with variable compositions that are not declared on the leaflet [package insert].
- The entire Infanrix Hexa analysis can be found here in English.
Emboldened by these findings, researchers tested two more vaccines, Hexyon and Gardasil 9.
Hexyon – Hexacima
Hexyon is a six-in-one shot to vaccinate against diphtheria, tetanus and pertussis (DTaP), polio, hepatitis B and Haemophilus influenza b (Hib). It is called a six-in-one vaccine; however, 8 vaccine antigens are actually present because the polio vaccine has three antigens (three separate viruses). The vaccine, manufactured by a partnership between Sanofi Pasteur and MSD (Merck), was approved for use in 2013 in Western European Countries; simultaneously, it was approved for use in Eastern European countries under the brand name Hexacima. Here is the package insert.
Using the same methods used to analyze Infanrix Hexa, Hexyon was found to have 216 toxic chemicals and contaminants, of which 70% could not be identified. An additional 16 toxic residues were present and thought to be cross-contaminants from different vaccines, meaning, the machines were not thoroughly cleaned between production runs.
Researchers confirmed that all three of the DTaP toxoid antigens were present in Hexyon. However, they shockingly discovered that the antigens for hepatitis B, HiB and polioviruses 1, 2 and 3 were all missing. The entire analysis of Hexyon can be found here in English.
For those who trust that vaccines provide protection, how can Hexyon be “effective” when only 3 of the 8 stated antigens are present? Even more, how can Hexyon be called “safe” when it contains cross-contaminants and more than 150 compounds that cannot be identified in any chemical databases?
In December 2018, the FDA approved Vaxelis for use in American children from 6 weeks through 4 years of age (prior to the 5th birthday). This is the same vaccine (Hexyon) produced by the same manufacturers (Sanofi Pasteur and MSD). The FDA’s provisional approval letter to the manufacturers clearly states:
You must submit reports of biological product deviations under 21 CFR 600.14. You should identify and investigate all manufacturing deviations promptly, including those associated with processing, testing, packaging, labeling, storage, holding and distribution. If the deviation involves a distributed product, may affect the safety, purity, or potency of the product, and meets the other criteria in the regulation, you must submit a report on Form FDA 3486 to the Director, Office of Compliance and Biologics Quality.
Corvelva’s published findings regarding the contaminants and unidentifiable compounds need to be urgently submitted to the FDA and CBER so approval of Vaxelis can be reviewed and hopefully, withdrawn.
Even though Gardasil is not mandatory in Italy, the vaccine has been associated with a large number of serious injuries and even death in countries around the world, including the US. Gardasil, the vaccine promoted to prevent cervical cancer and venereal warts associated with human papillomaviruses (HPV), was approved for use in girls in 2006 and then approved for boys in 2009. The vaccine contained four antigens: HPV subtypes 6, 11, 16 and 18.
In 2014, the FDA approved Gardasil 9 for use in girls. The following year, it was approved for boys and in 2018, approval was granted to give Gardasil 9 to individuals up to 45 years of age. The new formulation added five HPV subtypes to the mix – 31, 33, 45, 52 and 58 – and increased the amount of aluminum in each injection from 250mcg to 500mcg.
Corvelva’s analysis of Gardasil 9 found:
- Only 7 of 9 HPV antigens were present; subtypes 11 and 58 were not detected.
- 338 signals of chemical contaminants were detected, of which 78% were unknown.
- 10 chemical toxins, thought to be cross-contaminants from manufacturing of other vaccine production lines.
These findings again open questions about product compliance and clean manufacturing processes. The evidence should quickly be corroborated by other laboratories and if confirmed, reported immediately to the FDA, the European Commission on Vaccine Safety, the WHO, UNICEF, GAVI and corresponding bodies in all countries of the world.
If there is any doubt that vaccines may contain unknown, untested chemical contaminants, there can be no doubt that children must be protected from what is coming through that needle. A worldwide moratorium of the entire vaccination program must be implemented immediately until this investigation is concluded.
How do you gain the confidence to share this information with friends, family and your legislators? This is all part of the Spring 2019 Vaccine Boot Camp Course – mark your calendar for OPEN ENROLLMENT on February 21. The 8-week intensive course runs from March 4 to April 26. You won’t want to miss this! If you haven’t joined our early enrollment list yet, go to MasteringVaccineInfo.com and add your email – OR – text 555888 and put MVI in the subject line.